Contraceptive Clinical Trials Network - Female Sites08/01/2020 - 07/31/2027 (PI)
National Institute of Child Health and Human Development/NIH/DHHS
Pharmacokinetic/Pharmacodynamic Evaluation of Levonorgestrel Butanoate for Female Contraception09/28/2019 - 07/14/2025 (PI)
National Institute of Child Health and Human Development/NIH/DHHS
Refining a novel, non-hormonal, long-acting female contraceptive device07/01/2023 - 06/30/2025 (PI)
Massachusetts Life Sciences Center
Improvements in Reproductive Health Access, Infrastructure, and Security02/16/2023 - 06/30/2025 (PI)
Massachusetts Dept. of Public Health / DPH
MK8415-060 Nexplanon Extension: A Phase 3, Open-label, Multi-Center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger12/02/2020 - 12/01/2024 (PI)
Merck
Partners in Contraceptive Choice and Knowledge10/10/2019 - 09/30/2024 (PI)
Executive Office of Health and Human Services
Ovaprene Phase 1: Protocol Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal Device Clinical Trial09/28/2023 - 09/27/2024 (PI)
National Institute of Child Health and Human Development/NIH/DHHS75N94020D00004
Development of a novel, non-hormonal female contraceptive device09/01/2022 - 08/31/2024 (Multi-PI)
PI:
Katharine O. White, MD MPHVenova Technologies, Inc. NIH1R41HD111106-01
Massachusetts Sexual and Reproductive Health Training Center - PICCK24-1 - SDOH12/04/2023 - 06/30/2024 (Subcontract PI)
PI:
Katharine O. White, MD MPHJSI Research & Training Institute, Inc. Mass DPH
Birth Control to Improve Birth Spacing07/15/2021 - 06/30/2024 (Subcontract PI)
PI:
Katharine O. White, MD MPHBrigham and Womens Hospital NIH NICHD1R21HD103977-01A1
Showing 10 of 23 results.
Show All Results
Massachusetts Sexual and Reproductive Health Training Center - PICCK24-2 - CAB12/04/2023 - 03/31/2024 (Subcontract PI)
PI:
Katharine O. White, MD MPHJSI Research & Training Institute, Inc. Mass DPH
BAY 86-5028/1864910/02/2017 - 03/31/2024 (PI)
Bayer
Development and ex vivo evaluation of a novel, non-hormonal female contraceptive device for in vivo validation07/01/2021 - 02/29/2024 (PI)
Massachusetts Life Sciences Center
Phase 3 double-blind placebo-controlled efficacy trial of EVO100 vaginal gel for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection (EVOGUARD)02/11/2021 - 02/10/2024 (PI)
Evofem, Inc.
Clinical Evaluation of Long-Acting Reversible Contraceptives09/25/2015 - 09/27/2023 (PI)
National Institute of Child Health and Human Development/NIH/DHHS
Massachusetts Sexual and Reproductive Health Training Center01/01/2023 - 06/30/2023 (Subcontract PI)
PI:
Katharine O. White, MD MPHJSI Research & Training Institute, Inc. Mass DPH
Fellowship in Family Planning – General and Special Requirements- Sponsor to remain anonymous in all correspondence.07/01/2019 - 06/30/2023 (PI)
Susan Thompson Buffett Foundation
MDPH Sexual and Reproductive Health Training Center01/01/2022 - 06/30/2022 (Subcontract PI)
PI:
Katharine O. White, MD MPHJSI Research & Training Institute, Inc. Mass DPH
Contraceptive Clinical Trials Network - Female Sites : Core Function Activities06/26/2013 - 06/30/2021 (PI)
National Institute of Child Health and Human Development/NIH/DHHS
Freedom/Estetra
11/30/2016 - 11/30/2019 (PI)
Estetra SPRL
The IDEAS Study10/01/2017 - 09/30/2019 (PI)
Society of Family Planning
MK-8342B06/20/2016 - 02/28/2019 (PI)
Merck
Family Planning Fellowship Graduate Evaluation05/01/2017 - 06/30/2018 (PI)
Susan Thompson Buffett Foundation